Genetics 371B, Autumn 2000 Answer key, Problem set 4 |
1. | Remember that the question being asked is whether the given genotype increases the chance of cancer -- not whether the cell in question is itself a cancer cell. To answer the question, ask yourself in each case: Does changing the genotype from homozygous normal to the given genotype increase the risk of cancer? | |
(a) | Usually, it's the lack of tumor suppressor gene expression that is associated with an increased cancer risk. Therefore, increased expression of a tumor suppressor gene is not expected to increase the risk of cancer. | |
(b) | This is a gain of function mutation in a protooncogene; since protooncogenes are generally in pathways that promote cell proliferation, such a mutation is expected to increase the risk of cancer (the mutant form is dominant). | |
(c) | Failure to express a protooncogene is not expected to increase the risk of cancer. | |
(d) | Since tumor suppressor genes keep cell proliferation pathways in check, failure to express such a gene will increase the risk of cancer. | |
(e) | Again, loss of function of a protooncogene is not expected to increase the risk of cancer. | |
(f) | While the mutation is recessive, being heterozygous for the mutation increases the risk of cancer, because all it would take is mutation of the remaining allele (or a mitotic recombination event) for complete loss of the tumor suppressor gene. Therefore, this genotype does carry an increased risk of cancer. |
2. | (a) | In each cross, one parent is homozygous for one mutation and the other parent is homozygous for another mutation (which may or may not be in the same gene as in the first parent, and in fact, could even be the very same mutation -- we just don't know at this point). If the mutations are in different genes, the cross can be represented as aaBB x AAbb, and the progeny will be AaBb, heterozygous at both loci, and will therefore show a wild type phenotype (assuming that the mutant phenotype is recessive). If both mutations are in the same gene, the cross can be represented as a1a1 x a2a2, giving a1a2 progeny. Since these progeny lack wild type alleles of gene A, they will not show wild type phenotype. Therefore, to identify the mutations that belong in the same complementation group, one just identifies pairwise crosses that fail to give wild type progeny. For example, mutations r1 and r3 fail to complement, so those mutations are members of the same complementation group.
By applying this logic, the three complementation groups are:
Again, in order to get complementation (i.e., to get wild type phenotype when crossing mutations in two separate genes) the mutant phenotype has to be recessive -- if the mutant phenotype is dominant, we wouldn't see the wild type phenotype even in the heterozygotes. Therefore, none of these mutations had a dominant phenotype. |
(b) | Note: Your answer is not expected to be this long! I am jut spelling out the logic explicitly here.
We can come up with a working hypothesis (i.e., a hypothesis that we'll work with, and modify or discard if need be) by looking at the various phenotypes. First, the normal phenotype has brown and white coat color; there is no black coat. Therefore, the presence of black in a mutant suggests (but does not prove) the following: black color is normally converted to something else (such as brown or white), but that conversion has failed in the mutant. Since the mutation that gives black coats is dd, the wild type gene D is presumably (in this hypothesis) responsible for converting black to something else:
Furthermore, since D is epistatic to the other genes (i.e., in the absence of gene D, we get a black coat phenotype, regardless of the genotype of the other two genes), we can hypothesize that the action of gene D must be requied early in the pathway, before the action of genes B and E. What is that "something else" that brown is converted to? The simplest hypothesis is that that something else is either white or brown. Let us consider each of these two possibilities: Possibility 1: Black is converted to white.
Possibility 2: Black is converted to brown.
This pathway is also consistent with the cross described: the F2 progeny from the F1 cross (DdEe x DdEe) will be:
giving a 9 wild type : 4 black : 3 brown ratio, which is exactly what is seen. |
|
3. | A strain lacking gene G can be rescued by any intermediate; therefore, the function of G must be to synthesize the very first intermediate from the precursor:
By the same logic, supplement #3 does rescue a defect in gene H, and that is the only supplement that rescues, so supplement #3 must be the last intermediate in the pathway, and gene H is required for its synthesis; also, since a mutation in gene F is not rescued by any intermediate, itmust be required to convert the last intermediate (#3) into tryptophan. So the complete pathway is:
|
4. | (a) | These mutations are polar mutations; the genes are in the order:
Transcription begins at the promoter and extends rightwardto make a polycistronic mRNA, such that a mutation that causes premature termination of translation in gene B also results in failure to translate D and A, etc. |
(b) |
|
|
(c) | The goal here is to come up with ONE GENOTYPE such that if hypothesis (i) is correct, we should get a phenotype for that genotype, and if hypothesis (ii) is correct, we get a different phenotype -- so that by looking at the phenotype, we can tell which hypothesis is correct.
The major difference in the expected behavior of a promoter vs. an activator is that a promoter acts in cis -- it only affects the genes that it is located upstream of -- whereas an activator is expected to behave in trans -- it does not matter where the activator gene is, it can affect its target anywhere in the genome. We can make use of that difference to distinguish between these two hypotheses. For example, a partial diploid of the genotype:
will distinguish between the two hypotheses (b, d, and a being mutant alleles of B, D and A)--
|
5. | This one is just to get you thinking about selections and screens. In this particular instance, a selection is trickier than one might think initially. One could come up with various cruel and unusual schemes (e.g., surviving attacks by mouse-hungry cats), but they probably wouldn't be attempted in real labs. Instead, we could use some scheme where laser- and non-laser-mice could be separated based on the lasering itself. For example, we could set up a bin with passages leading out of the bin. The passages are branched and have laser-activated, fast-swinging doors (or trapdoors) so that mice that shoot lasers go one way (and, for instance, end up in a bin with lots of cheese and sunflower seeds, so they mice stop being angry) and non-laser mice go another way. We'd have to calibrate the laser-activated doors to respond only to a suitable laser strength, and we'd need some way of aggravating the mice (cat sounds?). Lastly, mice selected this way would have to go through a secondary screen, or perhaps be subjected to the same treatment again, to get rid of false positives. The main feature in this scheme is that we don't examine each mouse on an individual basis -- the mice are all dumped into the initial bin, and ones we want end up in one bin at the end, while ones we don't want are excluded. There are all sorts of other problems, of course -- for example, we have to keep the mice all happy, or they could end up killing each other. |